507 results on '"Wassmer, Evangeline"'
Search Results
2. Long term outcome in non-multiple sclerosis paediatric acquired demyelinating syndromes
3. Impact of autoantibodies against myelin oligodendrocyte glycoprotein in paediatric acquired demyelinating disease: Intellectual functioning and academic performance
4. Genome sequencing and comprehensive rare-variant analysis of 465 families with neurodevelopmental disorders
5. Performance of the 2023 Adult Criteria for the Radiologically Isolated Syndrome in Children and Comparison to the 2009 Criteria (P4-6.007)
6. Linking brain networks to cognition with magnetoencephalography in paediatric autoimmune encephalitis
7. A framework for measurement and harmonization of pediatric multiple sclerosis etiologic research studies: The Pediatric MS Tool-Kit
8. Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG
9. Examining cognition and brain networks using magnetoencephalography in paediatric autoimmune encephalitis and acute disseminated encephalomyelitis: a preliminary study.
10. Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial
11. Repurposing Clinical MRI Archives for Multiple Sclerosis Research with a Flexible, Single-Modality Approach: New Insights from Old Scans
12. Acute neurological deficit: is it demyelination?
13. Current international trends in the treatment of multiple sclerosis in children –impact of the COVID-19 pandemic
14. E.U. paediatric MOG consortium consensus: Part 3 – Biomarkers of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
15. E.U. paediatric MOG consortium consensus: Part 5 – Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
16. E.U. paediatric MOG consortium consensus: Part 4 – Outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
17. E.U. paediatric MOG consortium consensus: Part 1 – Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
18. E.U. paediatric MOG consortium consensus: Part 2 – Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
19. Evolution of brain MRI lesions in paediatric myelinoligodendrocyte glycoprotein antibody- associated disease (MOGAD) and its relevance to disease course.
20. Evolution of brain MRI lesions in paediatric myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and its relevance to disease course
21. Neuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis
22. Gross Motor Function in Pediatric Onset TUBB4A-Related Leukodystrophy: GMFM-88 Performance and Validation of GMFC-MLD in TUBB4A
23. Do Early Relapses Predict the Risk of Long‐Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?
24. International Pediatric MS Study Group Clinical Trials Summit
25. Clinical spectrum of POLR3-related leukodystrophy caused by biallelic POLR1C pathogenic variants
26. Real-World Effectiveness of Ocrelizumab in a Multi-Centre Pediatric-Onset Multiple Sclerosis (POMS) Cohort in the United Kingdom (S31.007)
27. Dynamic MRI Lesion Evolution in Pediatric Myelin-Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) (S27.006)
28. Evolution of brain MRI lesions in paediatric myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and its relevance to disease course
29. Implementation and Early Evaluation of a Quantitative Electroencephalography Program for Seizure Detection in the PICU*
30. Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment
31. Efficacy and safety of cyclic pyranopterin monophosphate substitution in severe molybdenum cofactor deficiency type A: a prospective cohort study
32. VAMP2Gene-Related Neurodevelopmental Disorder: A Differential Diagnosis for Rett/Angelman-Type Spectrum of Disorders
33. VAMP2 Gene-Related Neurodevelopmental Disorder: A Differential Diagnosis for Rett/Angelman-Type Spectrum of Disorders.
34. Radiologically isolated syndrome in children: Clinical and radiologic outcomes
35. Development of an Innovative SQL-Based Approach to Identify Potential Patients with Neurotransmitter Disorders
36. Childhood CNS inflammatory demyelinating diseases
37. Childhood arterial ischaemic stroke incidence, presenting features, and risk factors: a prospective population-based study
38. Progressive deafness–dystonia due to SERAC1 mutations: A study of 67 cases
39. Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension
40. Biallelic variants in ZNF142 lead to a syndromic neurodevelopmental disorder
41. 143 Is it ‘CLIPPERS’? Is it CNS Hemophagocytic Lymphohistiocytosis (HLH)?
42. An approach to developmental regression
43. Clinical features, investigations, and outcomes of pediatric limbic encephalitis:A multicenter study
44. Thiamine deficiency in childhood with attention to genetic causes: Survival and outcome predictors
45. Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in the United Kingdom
46. Clinical features, investigations, and outcomes of pediatric limbic encephalitis: A multicenter study
47. Pathogenic antibodies to AQP4:Neuromyelitis optica spectrum disorder (NMOSD)
48. Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study
49. Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial
50. Pathogenic antibodies to AQP4: Neuromyelitis optica spectrum disorder (NMOSD)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.